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Human neural stem cells (hNSCs) hold great promise for the treatment of neurological diseases.
Considerable progress has been made to induce neural differentiation in the cell culture in vitro and upon
transplantation in vivo [2] in order to explore restoration of damaged neuronal circuits. However, in vivo
conventional strategies are limited to post mortem analysis. Here, we apply our developed ﬁrst fate
mapping platform to monitor neuronal differentiation in vivo by magnetic resonance imaging, biolu-
minescence imaging, and ﬂuorescence imaging. Ferritin, Luciferase and GFP under neuronal-speciﬁc
promoters for immature and mature neurons, respectively, were used to generate transgenic hNSCs.
Differentiation-linked imaging reporter expression was validated in vitro. The time proﬁle of sponta-
neous neuronal maturation after transplantation into mouse brain cortex demonstrated early neuronal
differentiation within 6 weeks. Fully mature neurons expressing synaptogenesis were observed only
after three months or longer. Our trimodal fate mapping strategy represents a unique non-invasive tool
to monitor the time course of neuronal differentiation of transplanted stem cells in vivo.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Signiﬁcant progress in neural stem cell biology and directed
neural differentiation [1] during the past decade is now gradually
translating into a number of new and promising methods for
modeling and treating various neurological diseases [3,4]. Pure
populations of in vitro cultivated neural stem cells (NSCs) are a
versatile model for studying the mechanisms behind stem cell-
induced regeneration. Engrafted human NSCs (hNSCs) in the ro-
dent brain have been proven to form cells of all neural subtypes in
both, naïve and disease states [2,5]. Furthermore, xenografted cells
stopped proliferation, could survive without forming tumors for at
least 4 months, and differentiated to mature neurons [6]. In
contrast to mature neurons, NSCs respond to extrinsic morphogens, Max Planck Institute for
€oln, Germany. Tel.: þ49 221
Ltd. This is an open access article u[7e9] which facilitate graft integration. Alternatively, stem cell-
mediated regeneration may be driven by the secretion of neuro-
trophic factors and immune modulatory effects [10]. Convention-
ally, invasive histology and microscopy, together with ﬂow
cytometry, RT-PCR or Western blotting are used to identify stem
cell fate. Repetitive evaluations of the dynamic processes of in vivo
maturation are thus not available on the basis of such snapshot in
situ and ex vivo data but would be crucial for a better understanding
of the spatio-temporal and functional dynamics of stem cell grafts.
A consequential step has therefore been the present application of
our developed novel, highly sensitive approach for longitudinal
in vivo cell fate imaging to monitor hNSC fate after transplantation
in the brain.
Here, we generated transgenic hNSCs expressing imaging re-
porters for magnetic resonance imaging (MRI), bioluminescence
imaging (BLI) and ﬂuorescence imaging (FLI), under the control of
neuronal cell-speciﬁc promoters. After studying the reliability
of promoter activation in vitro cells were transplanted into the
cortex of mice. The transplanted cells stopped proliferation, were
viable during at least 6 weeks, and clearly differentiated intonder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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neurons. We describe a straightforward and highly efﬁcient pro-
tocol to longitudinally monitor in vivo neuronal differentiation of
intracerebral stem cell grafts in real time over extended periods of
time of several weeks to months.
2. Materials and methods
2.1. Cell culture
We used a commercially available human neural stem cell line (Life Technolo-
gies), which was initially derived from the NIH-approved human embryonic stem
cell line H9 (WA09) and is termed in the following H9 hNSCs [11e13].
The cell line was maintained according to the manufacturer's protocol under
humidiﬁed conditions at 37 C and 5% CO2. Brieﬂy, cells were cultured on Geltrex
coating at a density of 5  104 cells/cm2 in StemPro NSC SFM complete medium
consisting of 1 KnockOut DMEM/F-12, 2 mM GlutaMax, 20 ng/ml bFGF and EGF and
2% StemPro supplement (Life Technologies). To maintain them in undifferentiated
state, cells were passaged every 3 days and detached with accutase (PAA). Neural
differentiation was initiated for 37,500 cells/cm2 plated on polyornithine/laminin
coating (SigmaeAldrich). After an initial proliferation phase of 48 h, themediumwas
changed to Neurobasal medium supplemented with 2 mM GlutaMax and 1 B27
(Life Technologies) and the cells were cultured under hypoxic conditions (2.5% O2)
for up to 21 days.
2.2. Cloning
Lentiviral plasmids were designed for multicistronic expression of three imag-
ing reporters: i) the murine heavy chain of the iron storage protein Ferritin (Fer)
with a Human inﬂuenza hemagglutinin (HA) tag [14], ii) the bioluminescence re-
porter ﬁreﬂy luciferase (Luc2) from Photinus pyralis (Promega), and iii) the enhanced
green ﬂuorescent protein (copGFP ¼ GFP) from Pontenilla plumata. The self-cleaving
2A-like peptide sequences P2A and T2A [15] were used to provide nearly equimolar
expression of all imaging reporters independent of the upstream distance from the
promoter. The lentiviral backbone pCDH-EF1a-MCS-T2A-copGFP (System Bio-
sciences) contains the human elongation factor 1 alpha (EF1a) promoter, which was
shown to be beneﬁcial in terms of transgene stability especially in stem cells [16].
Plasmid DNAwas cloned by ampliﬁcationwith speciﬁc primers (SI Table 1) designed
to ﬁt restriction enzymes necessary for ligation in the multiple cloning site (MCS) of
pCDH-EF1a-MCS-T2A-GFP to produce pCDH-EF1a-Fer-P2A-Luc2-T2A-GFP. The
constitutive promoter EF1a was exchanged by cell-speciﬁc promoters, for early
differentiated neurons the doublecortin (DCX) promoter was chosen (kind gift of
Sebastien Couillard-Despres) and for matured neurons Synapsin I (SYN) promoter
restricted to synaptically connected neurons (Invivogen) was selected. The ﬁnal
plasmids for transduction were i) pCDH-EF1a-Luc2-T2A-GFP, ii) pCDH-DCX-Fer-
P2A-Luc2-T2A-GFP, and iii) pCDH-SYN-Fer-P2A-Luc2-T2A-GFP.
2.3. Transduction
A 3rd generation HIV-lentiviral vector expression systemwas used consisting of
the pCDH plasmid containing viral genetic elements, and the packaging plasmids
pPACKH1-GAG, pPACKH1-REV and pVSV-G providing the structural replication and
integration proteins (System Biosciences). Pseudoviral particles were produced by
transfection (Lipofectamine Plus, Life Technologies) of 293T cells with 2.25 mg
pPACKH1 packaging plasmid mix and 1 mg target vector in Optimem (Life Tech-
nologies). In the following days 293T cells were incubated at 32 C and 5% CO2 for
optimal virus generation. The virus supernatant was collected und subsequently
used for lentiviral infection of the H9 hNSCs facilitated by addition of 8 mg/ml Pol-
ybrene (SigmaeAldrich). Transgene expressing cells were sorted via FACS for high or
medium levels of GFP (103e104 counts, respectively 102.5e103). The inﬂuence of
transduction on cell viability was checked by repetitive counting of viable cells with
the Trypan blue exclusion assay (mean of 6e8 passages). Cell proliferation was
monitored during 5 passages of transduced cell lines and normalized to thewildtype
(WT) cells.
2.4. Cell speciﬁcation by RT-PCR
A gene marker proﬁle analysis via reverse transcription polymerase chain re-
action (RT-PCR) of 6 genes was performed to prove consistency between WT and
transduced cells. Total RNA (1 mg) was isolated using the Nucleo Spin RNA II Kit
(MachereyeNagel) and used for single strand cDNA synthesis with the Omniscript
RT Kit (Qiagen). The primer pairs were designed using the Primer-Blast tool from the
National Center for Biotechnology Information (NCBI). Primers were selected to span
exoneexon junctions in the reference sequence, if possible (SI Table 2). For PCR
reaction Biotherm DNA Polymerase was used according to manufacturer's protocol
(GeneCraft), followed by electrophoresis (1% agarose gel, TrisHCL, 100 V, 45 min).
2.5. Cell speciﬁcation by qPCR
Quantitative polymerase chain reaction (qPCR) was performed on a 7900HT Real
Time PCR system (Applied Biosystems) using the sample cDNA and the Taqman 2Universal PCR mastermix, No AmpErase UNG (Applied Biosystems) was used as
Master Mix. Custom-made TaqMan probes against doublecortin (DCX), Synapsin I
(SYN), Ferritin (Fth1), copGFP (GFP), Luciferase 2 (Luc2), 18S and b-Actin were ob-
tained from Applied Biosystems and are listed in SI Table 3. The mean of both
housekeeping genes (18S and b-Actin) was used to calculate the relative expression
of the target genes.
2.6. Western blotting
Western blot analysis was performed using a standardized setup with
commercially available consumables (Life Technologies). Cell lysates were obtained
by scraping with 5 ml/cm2 complete lysis buffer (10 ml stock: 9 ml 1 Cell Lysis
Buffer (Cell signaling) þ 5 ml PMSF þ Protease inhibitor cocktail tablet (Roche)). The
mixture was kept on ice for 30 min and vortexed occasionally, followed by 20 min
centrifugation (20,000  g, 4 C). Protein content was determined with the BCA
protein assay. For each protein analysis, 25 mg of total lysate protein were subjected
to SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose mem-
branes. Membranes were blocked with 5% non-fat dry milk in TBST for 1 h.
Immunolabeling of the blots occurred overnight at 4 C with the primary antibody,
followed by the HRP-coupled secondary antibody for 1 h at RT. Immunolabeling was
detected on an X-ray ﬁlm using the ECL developer solution (list of used antibodies SI
Table 4).
2.7. Quantitation of intracellular iron
Non-differentiated or 12 days differentiated cells were incubated with 2 mM
ammonium iron(III) citrate (FAC) for further 2 days. Cells were detached, counted
and processed, as previously described [17]. Brieﬂy, cells were lysed in 20 ml NaOH
for 2 h (2  104 cells/ml NaOH). 20 ml supernatant was mixed with 20 ml 10 mM HCl
and 20 ml of iron releasing reagent (equal volumes of 1.4 M HCl and 4.5% (w/v) KMnO4
in H2O) and incubated for 2 h at 60 C. Standard (0e600 mM FAC) was treated the
same as samples. After cooling to room temperature, 8.4 ml (10e14% of total volume)
of iron-detection reagent (6.5 mM ferrozine, 6.5 mM neocuproine, 2.5 M ammonium
acetate, 1 M ascorbic acid in H2O) was added and incubated for 30 min. 50 ml of each
sample or standard was transferred into a well of a 96-well plate and absorbance
was measured at 570 nm using a microplate reader (Berthold).
2.8. In vitro imaging set-up
Neural differentiation was monitored in vitro by repetitive imaging of GFP and
Luc2. Fluorescencewas acquired using amicroplate reader (Berthold) equippedwith
a 488 nm emission ﬁlter in PBS solution. For BLI, 1 mM D-luciferin potassium salt
dissolved in PBS (Synchem) was added to the cells and immediately afterwards
acquisition was performed for 30 min using Photon Imager (Biospace Lab). Lucif-
erase substrate was washed out by medium exchange after measurements. For each
differentiation experiment one 4-well plate was used for imaging and cell counting.
2.9. Experimental animals
NMRI-Foxn1nu/Foxn1nu mice (8e10 wk, 25e30 g, male from Janvier Labs)
received implantations of 3  105 of either the transduced H9 hNSCs cell lines,
named H9 EF1a-Luc2-GFP (n ¼ 4) or H9 DCX-Fer-Luc2-GFP (n ¼ 6) or H9 SYN-Fer-
Luc2-GFP (n ¼ 2). Animals underwent sequential BLI and MRI up to 6 weeks
(respectively, up to 3 ½ months for H9 SYN-Fer-Luc2-GFP cell line) and were
perfused after the last imaging session. All experiments were conducted according
to the guidelines laid out in the German Animal Welfare Act and approved by the
local authorities (Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-
Westfalen, reference number 84-02.04.2011.A123, dated 22 May 2007). Animals
were housed in cages under a 12 h light/12 h darkness cycle with access to food and
water ad libitum.
2.10. In vivo imaging set-up
Longitudinal BLI was performed on the day of transplantation (approx. 2 h post
transplantation surgery) and the following 6 weeks with at least 2 measurements
per week. Awake mice were injected i.p. with 300 mg/kg D-luciferin potassium salt
dissolved in PBS and subsequently anesthetized with 2% Isoﬂurane in 100% O2 ac-
cording to our previously optimized protocol for neuroimaging [18]. The time lag
between substrate injection and acquisition start was recorded for each experiment
and used for time-line correction. Bioluminescence was recorded in list mode for
30 min with the Photon Imager.
2.11. Cell transplantation
Mice were anesthetized with Isoﬂurane in O2:N2O (30:70%), and 4 mg/kg Car-
profen (Pﬁzer) was injected s.c. for analgesia. During surgery, mice remained ﬁxed in
a stereotactic frame (Stoelting). The skull was exposed by a small incision and one
hole was drilled for implantation at the following coordinates relative to bregma:
APþ0.6; Lþ2.0; DV0.6 using a stereotactic instrument (Stoelting). H9 hNSCs were
resuspended in HBSS before implantation at a concentration of 150,000 cells per mL,
and placed on ice during surgery. 2.0 ml of the NSC suspensionwere injected into the
brain through a Hamilton syringe (26G needle) using amicropump systemwith ﬂow
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place for 5 min and the wound was closed with a non-colored suture (Resorba).
2.12. Magnetic resonance imaging
MRI was carried out on a Biospec 9.4 T/16 cm dedicated animal scanner system
(Bruker BioSpin) equipped with actively shielded gradient coils (BGA9S, 750 mT/m,
Bruker BioSpin). For radiofrequency transmission and reception, we used a quad-
rature coil (Bruker mouse surface coil) and 11.6 cm resonator, respectively. Mice
were anesthetized with 2% Isoﬂurane in 100% O2. Respiration rate was monitored
using a pressure sensitive pad placed under the thorax, together with DASYlab
software (Measurement Computing), body temperature was maintained at 37 C
with a feedback controlled system (medres, Cologne). Animals were ﬁxed with ear
bars in standard animal holders (Bruker BioSpin). Field maps were acquired to
monitor additional local shimming (repetition time (TR)/echo time (TE) ¼ 20 ms/
2 ms, ﬁeld of view (FOV) ¼ 3.5  2.0  2.0 cm2, matrix ¼ 128  64  64,
bandwidth ¼ 200 kHz). Anatomical T2-weighted MRI was performed with a turbo
spin echo sequence (TR/TE ¼ 3000 ms/33 ms, 10 coronal slices, slice
thickness ¼ 0.5 mm, FOV ¼ 2.5  2.5 cm2, matrix ¼ 256  256,
resolution ¼ 98  98 mm2, number of averages ¼ 2, bandwidth ¼ 40 kHz). A multi
slice multi echo (MSME) sequence (TR/TE ¼ 5000 ms/10 ms, 16 echoes, 10 coronal
slices, slice thickness 0.5 mm, FOV 2.5  2.5 cm2, matrix 256  256, resolution
98  98 mm2, bandwidth ¼ 75 kHz) was measured for T2 evaluation and a multi
gradient echo (MGE) FLASH sequence (TR/TE ¼ 1500 ms/3.5 ms, 12 echoes, 10 cor-
onal slices, slice thickness 0.5 mm, FOV 2.5  2.5 cm2, matrix 128  128, resolution
195  195 mm2, bandwidth ¼ 78 kHz) was measured for T2* evaluation.
2.13. Electrophysiology
Electrophysiological experiments were performed on brain slices containing the
cortex with engrafted DCX-Fer-Luc2-GFP hNSCs 28e32 days after transplantation
and on cultured DCX-Fer-Luc2-GFP hNSCs as controls. For brain slice preparations,
the mice were anesthetized with halothane (SigmaeAldrich) and subsequently
decapitated. The brain was rapidly removed and a block of tissue containing the
cortex with the engrafted hNSCs was immediately cut out. Coronal slices of 300 mm
were cut with a vibrating microtome (Thermo Scientiﬁc) under cold (4 C), carbo-
genated (95% O2 and 5% CO2), glycerol-based modiﬁed artiﬁcial cerebrospinal ﬂuid
(GaCSF) [19] to enhance the viability of neurons. GaCSF contained (in mM) 250
glycerol, 2.5 KCl, 2 MgCl2, 2 CaCl2, 1.2 NaH2PO4, 10 HEPES, 21 NaHCO3, 5 glucose,
adjusted to pH 7.2 (with NaOH) resulting in an osmolarity of ~310mOsm. Brain slices
were transferred into carbogenated artiﬁcial cerebrospinal ﬂuid (aCSF). First, they
were kept for 20 min in a 35 C recovery bath and then stored at room temperature
(24 C) for at least 30min prior to recordings. The aCSF contained (in mM): 125 NaCl,
2.5 KCl, 2 MgCl2, 2 CaCl2, 1.2 NaH2PO4, 21 NaHCO3, 10 HEPES and 5 glucose adjusted
to pH 7.2 (with NaOH), resulting in an osmolarity of ~310 mOsm. Cultured hNSCs
were grown on Geltrex-coated, 24-well-plate coverslips (Life technologies) in me-
dium for two days. Shortly (~10 min) before the experiments the cell culture me-
dium was replaced by aCSF.
Brain slices or coverslips with cultured DCX-Fer-Luc2-GFP hNSCs were trans-
ferred to a recording chamber (~3 ml volume) and continuously superfused with
carbogenated aCSF at a ﬂow rate of ~2 ml min1 (for brain slices) or ~1 ml min1 (for
cultured hNSCs). Experiments were performed at ~31 C using an inline solution
heater (Warner Instruments) operated by a temperature controller (Warner In-
struments). hNSCs were visualized with a ﬁxed-stage upright microscope
(Olympus), using a 60 water immersion objective (LUMplan FI/IR; 60; 0.9 nu-
merical aperture; 2 mm working distance; Olympus) with infrared-differential
interference contrast [20] and ﬂuorescence optics. In brain slices, engrafted DCX-
Fer-Luc2-GFP hNSCs were identiﬁed by their GFP ﬂuorescence. Current-clamp re-
cordings were performed with an EPC10 patch-clamp ampliﬁer (HEKA) controlled
by the PatchMaster software (version 2.43; HEKA) running under Windows. Data
were sampled at 10 kHz and low-pass ﬁltered at 2 kHz with a four-pole Bessel ﬁlter.
The liquid junction potential between intracellular and extracellular solution was
compensated (14.6 mV; calculated with Patcher's Power Tools plug-in (version 2.19)
downloaded from http://www3.mpibpc.mpg.de/groups/neher/index.php?
page¼software for Igor Pro 6 [Wavemetrics]).
Perforated patch recordings were performed using protocols modiﬁed from
Horn & Marty [21] and Akaike & Harata [22]. Patch pipettes with tip resistances
between 3.5 and 5 MOhm were fashioned from borosilicate glass (0.86 mm inner
diameter; 1.5 mm outer diameter; GB150-8P; Science Products) with a vertical
pipette puller (Narishige). The internal solution used for perforated patch clamp
recordings was free of ATP and GTP and contained (in mM): 128 K-gluconate, 10 KCl,
10 HEPES, 0.1 EGTA, 2 MgCl2 and adjusted to pH 7.3 (with KOH) resulting in an
osmolarity of ~300mOsm. ATP and GTPwere omitted from the intracellular solution
to prevent uncontrolled permeabilization of the cell membrane [23]. The patch
pipette was tip ﬁlled with internal solution and back ﬁlled with
tetraethylrhodamine-dextran (0.2 mg ml1, Invitrogen), biocytin (1%; Sigma) and
amphotericin B-containing internal solution (~200 mg ml1; Sigma) to achieve
perforated patch recordings. Amphotericin B was dissolved in dimethyl sulfoxide
(DMSO; ﬁnal concentration 0.4e0.5%; Sigma) andwas added to themodiﬁed pipette
solution shortly before use. The used DMSO concentration had no obvious effect onthe investigated neurons. A change from perforated to the whole-cell conﬁguration
was indicated by diffusion of tetraethylrhodamine-dextran into the cell. Such ex-
periments were rejected. To block voltage-gated sodium currents in brain slice re-
cordings, tetrodotoxin (TTX; 1 mM; BN0517, Biotrend Chemikalien GmbH) was added
to the normal aCSF and bath-applied at a ﬂow rate of ~2 ml min1.
After completion of the test protocols, perforated-patch recordings were con-
verted to the whole-cell conﬁguration, and biocytin was allowed to diffuse into the
cell for 3e5 min. Brain slices were ﬁxed in Roti-Histoﬁx (Carl Roth) overnight at 4 C
and subsequently rinsed in 0.1 M phosphate buffered saline (PBS; pH 7.2; three times
for 15 min each, RT). Afterwards, the slices were incubated in PBS-based blocking
solution containing 10% normal goat serum, 1% Triton X-100 for 1 h at RT and then
washed in PBS (three times for 15 min each, RT). Subsequently, brain slices were
incubated with DyLight 650-conjugated streptavidin (1:400, Abcam) dissolved in
PBS and 10% normal goat serum overnight at 4 C. Finally, brain slices were rinsed in
PBS (ﬁve times for 10 min each), dehydrated, cleared in xylene (Applichem) and
mounted in Permount (Fisher Scientiﬁc). The ﬂuorescence images were captured
with a confocal microscope (Carl Zeiss).
Confocal images were overlaid in ImageJ (version 1.45s) and ﬁnal ﬁgures were
prepared in Illustrator CS5 (Adobe). Data analyses were performed with Spike2
(Cambridge Electronics) and Igor Pro 6 (Wavemetrics).
2.14. Histology
Cells were ﬁxed by treatment with 4% PFA before immunocytochemistry
(ICC), which was performed as described in detail elsewhere [24] (list of used
antibodies SI Table 4). The nuclei were counterstained by Hoechst 33342 (Sig-
maeAldrich) and the cells ﬁnally mounted within Aquamount (Thermo Fisher
Scientiﬁc). ICC was visualized under a 60 or 40 objective on a ﬂuorescence
microscope (Keyence) and analyzed with ImageJ (Version 1.45d; National In-
stitutes of Health).
For immunohistochemistry (IHC), mice were perfused transcardially under
Isoﬂurane anesthesia with saline followed by 4% PFA. The brains were removed,
incubated overnight in 4% PFA, and the next day transferred to a 30% sucrose so-
lution for 2 days at 4 C. Brains were stored at 80 C. 14 mm thick sections were cut
in the coronal plane using a cryostat (Leica) and stored at20 C. IHCwas performed
on the basis of a previously described protocol [25] (list of used antibodies SI
Table 4). IHC was visualized under a 4, 10 and 60 objective on a ﬂuorescence
microscope (Keyence) and analyzed with ImageJ. For Iba-1 antigen retrieval was
applied as follows: sections were incubated in 10 mM citrate buffer for 30 min at
80 C, in the same solution at room temperature for 20 min and washed 3with 1
KPBS for 5 min. Sections were ﬁxed in 20 C acetone for 20 min and washed again
3 with 1 KPBS.
2.15. Data analysis and statistics
BLI data was analyzed using the M3 software (Biospace Lab) on region-of-
interest (ROI) basis. Further calculations, plotting and statistical analysis were
done with MS-Excel (Microsoft Corporation), Origin 8G (OriginLab Corporation)
and SPSS (Version 20, IBM SPSS statistics). Photon ﬂux from in vitro data on 4-well
plates was extracted by manually drawn ROIs covering each well surface. The mean
and standard deviation of 4 wells was calculated and later used for visualization.
For precise comparison of longitudinal BLI in vivo data, signal-to-noise ratio (SNR)
was calculated [18]. Size-constant ROIs were manually drawn over the brain, the
back of the animal to correct for inter-individual background, and a region outside
the animal (noise ROI). The background photon ﬂux was subtracted from the brain
photon ﬂux. The resulting value was divided by the standard deviation of the noise
ROI. Change in SNR is expressed in relation to ﬁrst data point (day of
transplantation).
Quantitative T2 and T2* maps were calculated using a custom-made program
developed in IDL (ITT Visual Information Solutions). The MRI signal S(TE) was ﬁtted
on a voxel basis with a monoexponential function S(TE)¼ Y0þ S0*exp(TE/T2) with
an initial onset Y0, equilibrium signal S0, echo time TE and transverse relaxation time
T2. For visualization purpose, brains were extracted automatically with FSL bet (FSL
tools, FMRIB Software Library; http://fmrib.ox.ac.uk/fsl). MR images were further
analyzed with ImageJ. To match individual location of the cell deposit, ROIs were
manually drawn on T2-weighted images based on histologically detected graft
location. ROIs were drawn for day 0, 5 and 33 on the adjacent slices anterior and
posterior to the implantation. Based on the ROI data for the selected time points, T2
and T2* maps of all animals were analyzed. The values for the implantation sitewere
divided by the contralateral hemisphere to correct for animal- and scanner-based
variations. The resulting ratio was set to 100% for day 0.
All statistical analyses were carried out in SPSS. For longitudinal investigations
repeated measures ANOVA was used, followed by post hoc pairwise comparison
with Bonferroni correction. A Student's t-test was used for the comparison of time
points and experimental groups for in vitro experiments. A p-value 0.05 was
considered to be signiﬁcant. qPCR results were statistically analyzed with REST
calculation as previously described [26]. All values are expressed asmean ± standard
deviation (SD).
SI Tables. For information about the primers and antibodies used in this study,
see Table S1eS4.
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3.1. Generation of transgenic hNSCs for noninvasive imaging
We have evaluated imaging reporters for fate mapping in vitro
and in vivo. Transgenic hNSCs were established expressing the
following three different genetic imaging reporters: i) Ferritin (Fer)
for structural MRI, ii) ﬁreﬂy luciferase 2 (Luc2) for BLI of viable cells,
and iii) the green ﬂuorescent protein copGFP (GFP) for locating the
cells back in histology [14,18,27]. Reporter expression was
controlled by the human doublecortin promoter (DCX) which has
been shown to efﬁciently target cells in the early phase of neuronal
differentiation in the mouse brain in vivo [28]. Reporter expression
according to the DCX promoter activity has been themain objective
of the study. In addition, we selected the promoter for Synapsin I
(SYN), a protein present in synaptic vesicles and upregulated in
mature neurons during synaptogenesis [29,30]. In control cells,
expression of Luc2 and GFP was driven by the elongation factor
alpha (EF1a) promoter, which constitutively promotes robust
transgene expression in stem cells during differentiation [16]
(Fig. 1A). 2A-like viral peptide sequences (P2A and T2A) were
used to clone highly efﬁcient multicistronic expression vectors [15].
We detected no difference in basic NSC marker expression after
transduction and subsequent ﬂuorescence activated cell sorting
(FACS) for GFP expression. The cells maintained a NSC-associated
gene proﬁle (GFAP/Sox2þ/Sox1/Pax6þ/Nestinþ) [31] (Fig. 1B
and C). Transduction did not alter cell vitality, cell proliferation
(Fig. S1A and B) and cell morphology. The majority of cells (>90%)Fig. 1. Generation of hNSCs for noninvasive in vivo imaging of the neuronal cell fate. (A)
reporters HA-Ferritin (Fer), Luciferase 2 (Luc2) and copGFP (GFP) are linked via T2A and P2A
SYN, or under the constitutively active promoter EF1a. Peptide 2A constructs (P2A and
Representative bright-ﬁeld image of H9 hNSCs. Scale bar: 50 mm. Fluorescence image of GFP,
naïve, undifferentiated state (GFAP/Nestinþ/Sox2þ). Scale bar: 20 mm. (C) Veriﬁcation of th
to WT cells for GFAP, Sox2, Sox1, Pax6, Nestin and GAPDH (as internal control). Scale bars:were immunoreactive for undifferentiated stem cell markers
(Nestin and Sox2) and negative for astrocyte marker (GFAP)
(Fig. 1B).
Live imaging of DCX- and SYN-related neuronal differentiation
in vitro was achieved by ﬂuorescence microscopy of the GFP-
positive cells over a period of 3 weeks, and quantitative ﬂuores-
cence data was collected with a plate reader during differentiation.
In parallel, quantitative bioluminescence signal intensity was
recorded during the 3 week differentiation period. Fluorescence
and bioluminescence measurements were normalized to the
number of viable cells at each time point in order to compensate for
cell proliferation and cell death. In control cells with constitutive
Luc2 and GFP expression, both signals increased slightly during the
differentiation period (BLI: p < 0.001, GFP: p ¼ 0.078). This effect
reﬂects a persistent proliferation, as normalized signals remained
constant. Notably, no signiﬁcant transgene down-regulation was
observed (Fig. 2). Early differentiation targeted with DCX-Luc2 and
DCX-GFP increased signiﬁcantly from day 4e7 (p ¼ 0.004) and was
most prominent between day 11 and 18 (p ¼ 0.01) with a total 86-
fold bioluminescence increase (Fig. 3A). In contrast, the imaging
markers of mature neuronal cells with Synapsin I expression
appeared signiﬁcantly later, i.e. between day 18 and 21 (BLI:
p ¼ 0.036, GFP: p ¼ 0.004) and with an overall weaker increase in
bioluminescence and GFP intensity (Fig. 3B).
The non-invasive and quantitative analysis of in vitro differen-
tiation matched with time proﬁles of maturation-dependent gene
regulation [32]. Based on our in vitro data we drafted a scheme of
the H9 hNSCs differentiation time proﬁle. The H9 hNSCsSchematic representation of the multicistronic, trimodal vector system. The imaging
to promote consistent expression under control of the cell-speciﬁc promoters DCX and
T2A) were used to clone highly efﬁcient multicistronic expression vectors [15]. (B)
and immunostaining of transduced hNSCs (EF1a-Luc2-GFP). Transduced cells remain in
e undifferentiated state on mRNA-level by RT-PCR. Transduced cells show no difference
50 mm (B, image 1); 20 mm (B, images 2e4).
Fig. 2. In vitro monitoring of constitutive promoter activity during neuronal maturation of hNSCs. Neuronal differentiation was induced by withdrawal of the epidermal growth
factor (EGF) and ﬁbroblast growth factor 2 (FGF-2), and by addition of speciﬁc differentiation medium. Hypoxic conditions were applied (2.5% O2) to enhance neuronal differ-
entiation [41]. Fluorescence and bright-ﬁeld images visualize the GFP expression and changes in cell morphology during neuronal differentiation. Constitutive promoter activity was
analyzed based on GFP ﬂuorescence images and Luc2 bioluminescence (0, 7, 14 and 21 days). Scale bar: 50 mm. Graphs represent Luc2 bioluminescence (photon ﬂux) and GFP
ﬂuorescence (relative ﬂuorescent units, RFU) quantiﬁcation, respectively. Signals were normalized to the number of cells (mean ± SD) for time points 0, 4, 7, 11, 14, 18 and 21 days.
A. Tennstaedt et al. / Biomaterials 44 (2015) 143e154 147differentiate within 4 days into early neurons. After 14 days mature
neurons have developed, and 21 days after differentiation start,
synapsin expression indicates emergence of synapse formatting
neurons (Fig. 3C). In addition, we performed a spectrophotometric
iron test, to assess levels of accumulated iron due to upregulation of
Fer during differentiation. A signiﬁcantly higher enrichment of iron
was observed in the differentiated H9 DCX-Fer-Luc2-GFP cells,
compared to non-differentiated cells (p < 0.001) (Fig. S1C).
3.2. Transgenic hNSCs show distinct promoter-driven reporter
activation upon differentiation
We further validated DCX promoter-driven imaging reporter
expression during in vitro neuronal differentiation by immunos-
tainings, qRT-PCR and Western blot. Increased immunoreactivity
was detected for anti-DCX, anti-Fer and anti-GFP at day 21 and
correlated precisely with endogenous GFP ﬂuorescence. In the
undifferentiated state, deﬁned by Sox2 expression, no background
expression of the cell-speciﬁc imaging reporters was detected in
the transgenic cells, as is visualizedwith the GFP expression (Fig. 4A
and Fig. S2A and B).
mRNA levels of DCX and SYN were quantiﬁed in relation to
imaging reporter mRNA (Fig. 4B). Negligible levels of DCX and SYN
were present before differentiation in transduced cells, as well as
wildtype (WT) cells. During neuronal differentiation, DCX and SYNgradually increased over time, with a 43-fold increase of expression
level at day 18 for DCX. Expression of trimodal imaging reporters
increased during differentiation with a similar time proﬁle of
promoter-controlled endogenous mRNA (DCX and SYN) but with a
lower extent (5-fold). It has been reported that an upstream pro-
moter region enhances DCX expression in differentiating neurons,
suggesting that these elements represent the higher factor [33]
relative to the increase of the imaging reporters. Notably, mRNA
levels for T2A- and P2A-coupled imaging reporters did not differ
(Fig. 4B). However, imaging reporter expression (Luc2 and GFP) was
5-fold higher for cells with the constitutive promoter compared to
the cell speciﬁc promoter. These results were conﬁrmed by West-
ern blot analysis of imaging reporter protein levels. Proteins of all
three reporters (Fer, Luc2, GFP) were upregulated simultaneously
with DCX during differentiation. Western blot also veriﬁed a lower
protein amount for SYN accompanied with a delayed expression
onset. Sox2 protein was detectable in undifferentiated cells and
protein amount decreased during differentiation period (Fig. 4C).
3.3. In vivo imaging of neuronal maturation of transplanted hNSCS
In order to examine the neuronal differentiation and integration
behavior of grafted hNSC into adult mouse brain in vivo, we
transplanted 3  105 H9 DCX-Fer-Luc2-GFP cells (n ¼ 6) or EF1a-
Luc2-GFP cells (n ¼ 4; control group) into the cortex of nude mice.
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week byMRI for 6 weeks (experimental schedule shown in Fig. S3).
Bioluminescence from engrafted hNSCs in the cortex of nude
mice was evaluated on the basis of signal-to-noise ratio (SNR)
calculations [18]. Transgenic hNSCs with constitutive expression of
Luc2 showed stable BLI signal intensity over time with constant
SNR throughout the whole observation period (Fig. 5B and C). DCX-
targeted hNSCs exhibited ﬁrst signiﬁcant bioluminescence increase
at 4 days post grafting and increased further until day 33 (41-fold
compared to day 0, p ¼ 0.022). However, between day 33 and 42
the Luc2 signal dropped by trend (Fig. 5A and C). At this time, a few
hNSCs were already found with immunohistochemical marker
NeuN of mature neurons (Fig. S4). We next examined the SYN
promoter activity in vivo. Still at 4 weeks (p ¼ 0.022) after trans-
plantation no signiﬁcant increase of Luc2 signal was detected. Yet,
after 3 months a pronounced signal increase was clearly noticeable
and continued to increase within the evaluated time of 3.5 months
(Fig. S5A and B). These results conﬁrm that BLI has the sensitivity to
follow cell speciﬁc promoter activity initiation and to monitor the
degree of activation in vivo in the brain.
For the second noninvasive imaging technique, MRI, T2- and T2*-
maps of the mouse brain were acquired. In correspondence to theFig. 3. In vitro in real-time monitoring of cell speciﬁc promoter activity during neuronal mat
of GFP expression and changes in cell morphology during neuronal differentiation (A) DCX
based on GFP ﬂuorescence images and Luc2 bioluminescence (0, 7, 14 and 21 days). Scale b
(relative ﬂuorescent units, RFU) quantiﬁcation, respectively. Signals were normalized to the
diagram to summarize the imaging reporter time proﬁle of DCX and SYN regulation duringBLI time proﬁle, only days 0, 5 and 33 were analyzed by a blinded
region-of-interest (ROI) analysis. These ROIs covered the MR im-
ages caudally and rostrally adjacent to the implantation canal. We
detected only small changes over time, only for T2* values of DCX
cells, indicating an iron storage effect of the DCX promoter driven
Ferritin upregulation. T2* values decreased by 31.3 ± 22.8% from
day 0e33 after transplantation. Notably, no signiﬁcant T2/T2* dif-
ference over time was measured for control cells (no Ferritin
overexpression) (Fig. S6).
3.4. hNSCs differentiate in vivo into early neurons
We validated the in vivo imaging results by electrophysiological
analysis of the hNSC grafts. Perforated patch clamp recordings were
performed on the engrafted DCX-Fer-Luc2-GFP hNSCs 28e32 days
after transplantation and on cultured DCX-Fer-Luc2-GFP hNSCs for
comparison. Bioluminescence data from engrafted hNSCs revealed
a peak of DCX promoter activity around day 33. We therefore
performed the electrophysiological study around this time point to
analyze the functional status of the transplanted cells at the highest
DCX promoter activity. All engrafted hNSCs generated action po-
tentials upon depolarizing current injection (Fig. 6A). TTXuration of hNSCs. Fluorescence and bright-ﬁeld images visualize the onset and increase
-Fer-Luc2-GFP, and (B) SYN-Fer-Luc2-GFP. Cell-speciﬁc promoter activity was analyzed
ar: 50 mm. Graphs represent Luc2 bioluminescence (photon ﬂux) and GFP ﬂuorescence
number of cells (mean þ SD) for time points 0, 4, 7, 11, 14, 18 and 21 days. (C) Schematic
neuronal differentiation of H9 hNSCs.
Fig. 3. (continued).
A. Tennstaedt et al. / Biomaterials 44 (2015) 143e154 149application abolished the action potentials in these recordings,
indicating the presence of voltage-gated sodium currents (Fig. 6A,
TTX sensitivity). Using biocytin-labeling, we observed that the
recorded hNSCs had developed neurites after transplantation
(Fig. 6B). In contrast to engrafted hNSCs in cortical brain slices,
cultured hNSCs did not exhibit sodium-driven action potentials
(Fig. 6C). Then, qualitative histology was performed on brains
stained after the 6 weeks observation period. Immunohistochem-
ical overview images (4magniﬁcation) were produced to localize
DCX and control cell grafts (Fig. 7A and F). Grafted cells were
distinguished from the host tissue by endogenous GFP ﬂuorescence
and immunostaining against the human-speciﬁc nuclei (HuNu).
The same cells showed strong immunoreactivity for anti-DCX andanti-HA (where the tag HA reﬂects the Ferritin expression) indi-
cating neuronal differentiation along with imaging reporter upre-
gulation (Fig. 7B and C). A similar level of DCXþ/GFPþ/HuNuþwas
detected in the control group (Fig. 7G and H).We also examined the
activation of microglia/monocytes by Iba-1 staining. No difference
in Iba-1-positive cells around the graft and the rest of the cortex
was observed, suggesting that the immune response was not
crucial for this cell graft (Fig. 7D). Co-labeling of human cells
(HuNu-positive) and proliferating cells (Ki67-positive) was not
observed, indicating that the BLI signal increase was not the result
of proliferating cells (Fig. 7E). Furthermore, a few transplanted cells
were NeuN-positive, indicating that after 6 weeks of trans-
plantation neuronal differentiation is advanced (Fig. S4). The
Fig. 4. Differentiation marker proﬁle correlates with cell-speciﬁc imaging reporter expression. (A) During differentiation H9 DCX-Fer-Luc2-GFP cells lose immunoreactivity for anti-
Sox2 but increase levels of anti-DCX, anti-HA and anti-Turbo-GFP (comparison of day 0 and day 21). Immunostainings correlated with up-regulation of the GFP transgene. Scale bar:
50 mm. Magniﬁcation of differentiated cells is shown in the bottom row. Scale bar: 100 mm. (B) Relative expression levels of imaging reporters (Ferritin, Luc2, GFP) in relation to
endogenous cell-speciﬁc promoter targets (DCX and Synapsin) evaluated by qRT-PCR. Cells with constitutive promoter (EF1a) and WT cells served as control (mean ± SD). (C)
Protein levels during differentiation were analyzed by Western blot (same controls as for qRT-PCR).
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mouse brain environment allows and actually stimulates differen-
tiation of transplanted hNSCs into early neurons, as indicated by
noninvasive imaging.4. Discussion
We describe here a new and highly sensitive protocol for func-
tional cell fate mapping to monitor in vivo neuronal differentiation
of transplanted hNSC with noninvasive imaging techniques.
Transgenic hNSCs were transplanted into nude mouse cortex and
monitored up to 6weeks by repetitive in vivoMRI and BLI, andwere
histologically traced by FLI.
This multimodal approach provides a unique in vivo temporal
characterization of the neuronal fate in addition to cell localization,
viability and function. Previously, reports have shown in vitro the
reliability of reporter gene expression due to promoter activation[16]. In agreement with these reports we have evaluated in our
study that the imaging reporter data clearly reﬂects activity of the
cell speciﬁc promoter during neuronal differentiation in corre-
spondence with the mRNA and protein levels (Fig. 4).4.1. Sensitive in vivo intra-cerebral cell fate mapping
Imaging reporter sensitivity remains a major challenge for
molecular neuroimaging. First studies showed a positive outcome
using bioluminescence reporters for neuroimaging [34,35]. In the
present study optical cell tracking with Luc2 was highly efﬁcient.
The bioluminescence signal signiﬁcantly increased until day 33.
Afterwards the Luc2 decreased. We believe that the decrease is
caused by ongoing neuronal maturation accompanied by a loss of
DCX, with a consequent non-signiﬁcant signal decrease at day 42
(Fig. 5A and C). Support for this interpretation comes from the
observation that some grafted cells expressed the mature
Fig. 5. Quantitative in vivo imaging of neuronal maturation of transplanted hNSCs. (A and B) Representative bioluminescence and photographic image overlays of nude mice for
weekly measurements (day 0 to day 42) show photon ﬂux increase for engrafted H9 DCX-Fer-Luc2-GFP (upper row) while strong signal of H9 EF1a-Luc2-GFP cells (lower row)
remains stable over the whole observation period (C) Signiﬁcant increase of bioluminescence signal in the H9 DCX-Fer-Luc2-GFP group (n ¼ 6) was detected 4 days after im-
plantation. No signiﬁcant increase was observed over time in the control group (n ¼ 4) (H9 EF1a-Luc2-GFP cells). Luc2 signal increase is expressed as the ratio between value at each
time point divided by value at day 0 (mean ± SD).
A. Tennstaedt et al. / Biomaterials 44 (2015) 143e154 151neuronal marker NeuN at 6 weeks after grafting, which supports
the interpretation of progressing neuronal maturation (Fig. S4). It
has been reported that DCX expression was barely detectable in
neurons positive for the more mature neuronal marker NeuN
[32]. Therefore, we think that the decrease of the DCX-dependentFig. 6. Electrophysiological and morphological characteristics of engrafted hNSCs. (A) Eng
transplantation upon depolarizing current injection. The generated action potentials were a
currents. (B) Biocytin-labeling of a recorded DCX-Fer-Luc2-GFP hNSC engrafted 28e32 days
voltage-gated sodium currents. (A and C) During current injections the resting membrane
60 ms of the voltage deﬂections that resulted from the injected current steps are shown.BLI signal after 4 weeks of transplantation (Fig. 5C) is most likely
due to progressing neuronal maturation of the cells, in accor-
dance with the following synapsin-dependent BLI signal uprise
(Fig. S5). This is further strengthened by our electrophysiological
pattern developments which are similar to earlier patch-clamprafted DCX-Fer-Luc2-GFP hNSCs (n ¼ 6) generated action potentials 28e32 days post
bolished by application of 1 mM TTX, indicating the presence of voltage-gated sodium
earlier in the cortex. (C) In culture, DCX-Fer-Luc2-GFP hNSCs (n ¼ 6) did not express
potential of hNSCc was clamped to 70 mV. For clarity, only the ﬁrst 200 ms and last
Fig. 7. Histological validation of in vivo neuronal differentiation. Histology of transplanted H9 DCX-Fer-Luc2-GFP cells (n ¼ 6) (AeE) and H9 EF1a-Luc2-GFP cells (n ¼ 4) (FeH) six
weeks after transplantation. GFP-transgene expression (green) and immunostainings with antibodies against: DCX, neuronal marker; HuNu, human nuclei marker; HA, against the
HA tag of Ferritin; Iba-1, immunoreaction; Ki67, proliferation marker. (A and F) Mice brain slice overview images conﬁrmed cortex location of the transplanted H9 DCX-Fer-Luc2-
GFP and H9 EF1a-Luc2-GFP cells. Scale bars: 500 mm (A and F); 10 magniﬁcation of transplant site 100 mm (BeE and GeH). (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
A. Tennstaedt et al. / Biomaterials 44 (2015) 143e154152characterization of doublecortin-expressing cells in the sub-
ventricular zone after ischemic stroke [36].
The low sensitivity of Ferritin unfortunately does not support
MRI's superior three-dimensional in vivo resolution, in line with
previously reported limitations [37]. The Ferritin overexpression
and accumulation of iron as ferrihydrite linked to neuronal differ-
entiation induced only small susceptibility changes, detectable only
by quantitative T2* mapping. The combination of BLI and MRI is
however desirable as the two modalities together provide com-
plementary visualization of differentiation as well as high resolu-
tion 3D-location of stem cells. To exploit this combined strength
better, we recommend for future studies to label cells with highly
sensitive superparamagnetic iron oxide (SPIO) or 19F contrast
agents for sensitive 3D cell localization [38,39].
The most widely used gene reporter, GFP, has been included for
cell relocation on tissue slices to allow for unambiguous selection of
cells for electrophysiology as well as for correlation with in vivoneuroimaging of the other gene reporters, particularly luciferase for
BLI. This has been demonstrated for validation of DCX- and SYN-
speciﬁc imaging reporter data which was found in good agree-
ment with ex vivo analysis, thus supporting the reliability of the
in vivo measurements.
4.2. Consequences for therapeutic strategies with stem cell grafts
Most importantly, we have been able to determine the neces-
sary period for neuronal differentiation of intracerebrally grafted
human stem cells. Within four weeks, the graft has differentiated
into DCXþ early neurons, directly followed by differentiation into
NeuNþ neurons. Full differentiation into mature neurons with ca-
pacity to integrate into the endogenous neuronal networks, as
represented by synaptogenesisþ neurons, requires several months,
beginning only at approx. three months after grafting. Earlier
studies exploring the therapeutic potential of stem cell grafts had
A. Tennstaedt et al. / Biomaterials 44 (2015) 143e154 153relied on invasive analysis of differentiation status of the graft and
of formation of neuronal circuits with endogenous neurons, sacri-
ﬁcing animals after several months [6,40]. Thus, a correlation of
cellular differentiation and integration capability with therapeutic
developments (e.g. behavioral improvement, functional recovery)
was almost impossible. With our approach we have now deter-
mined early and late phases of neuronal differentiation of human
stem cell grafts. Neuronal differentiation starts within the ﬁrst few
weeks but requires three or more months for complete maturation
and capacity of neuronal circuit formation under normal brain
condition. Using the cell fate imaging platform will in the future
allow the characterization of stem cell graft behavior under con-
ditions of stem cell mediated therapy of cerebral diseases, such as
e.g. stroke or neurodegeneration.
5. Conclusions
Using the presented new protocol we have demonstrated its
power to noninvasively visualize and quantify spontaneous differ-
entiation of engrafted hNSCs in longitudinal studies. The trimodal
reporter genes linked to neuron-speciﬁc promoters served as an
efﬁcient and sensitive tool to monitor the cell fate in the living
animal repetitively and over a period of up to 6 weeks or even
several months. It should be emphasized that the approach can be
translated to any promoter of interest for a broad range of longi-
tudinal in vivo investigations. This novel approach of cell-speciﬁc
imaging is of particular interest, as it provides the key tool to
track differentiation processes and to understand the mechanisms
underlying functional restoration in stem cell-based therapeutic
approaches.
Further future application ﬁelds of our cell fate imaging strategy
are envisioned to include the use of our H9 DCX-Fer-Luc2-GFP cells
in a screening assay to study the effects of pharmacological or
toxicological compounds on neuronal differentiation behavior.
Furthermore, we envision application of this protocol to monitor
in vivo neuronal differentiation of induced pluripotent stem cells
derived from patients with various diseases to understand deﬁcits
in neuronal development or function.
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